ENDRA Life Science’s (NDRA) $1.23 Fatty Liver Detector Advances to Next Stage of Review...
Gentleman start your engines!
Endra (NDRA) recently announced it has advanced to 'substantive review*' with the U.S. Food and Drug Administration (FDA) for its...
Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.
This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential customers.
Dedicated Plan...
Ranked: The Most Popular Drugs in the U.S.
Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.
The most prescribed...
Adding Dario Health (DRIO) $2.81 to Watch List.
LIVE QUOTE
Adding DarioHealth to Top Stocks of 2023 Watch List.
A position in Dario Health (DRIO) offers investors a brilliant back door, into the growing...
With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case for Its Diabetes...
We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company with a $80...
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.
LIVE QUOTE
Ardelyx Enters the Danger Zone* With Tenapanor.
The company produced favorable (albeit very technical) information (data) at the National Kidney Foundation 2023 Spring Clinical...
We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.
And up 416%, from Adding it to 2022 Watch List!
Great way to wake up after a night of hard partying at the C-3.
How pray...
Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.
Stormin..Live Quote
We're still not sure how to pronounce it...but Wall Street likes it.
News Archive
Unicycive Therapeutics (UNCY) $2.73. We're now up 249%.
Unicycive (UNCY) Shoots and...
Unicycive (UNCY) Shoots and Scores, up 40% Today!
We're up 126% Since December, and That Ain't Bad.
Note: This isn't the end, it's just the beginning.
LIVE QUOTE
Adding Unicycive (UNCY) $0.75 to...
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers. Unicyive...
Los Altos, CA --News Direct-- Unicycive Therapeutics, Inc.
By Julian Richard, Benzinga
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company committed to developing effective and safe...
Latest article
Everything You Need to Know on Carlin-Type Gold Deposits
Nevada is one of the world’s most productive gold-mining regions, and it’s the high-grade Carlin-type gold deposits (CTGDs) that put the Silver State on...
Fairchild (FAIR) Soars 33% on News of Large Investor Stake.
Okay that headline, while factual is a bit of 'click-bait,' so let's not get too excited!
But it is indeed excellent news.
The stock...
Replimune (REPL) $10.07. Our Analyst Sells.
Inside the Wild Ride of Replimune (REPL). We're Up And Out, With 360% Gain.
Shareholders (for now) are enjoying massive $657 million gain, in just...
